# André Scheen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andre-scheen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,242 |
| Field | Diabetes Treatment and Management |
| h-index | 82 |
| i10-index | 365 |
| Last Known Institution | University of Liège |
| OpenAlex ID | https://openalex.org/A5039563874 |
| ORCID iD | https://orcid.org/0000-0001-9743-4371 |
| Works | 1,534 |

## Researcher papers

- [Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial](https://scholariq.org/papers/secondary-prevention-of-macrovascular-events-in-patients-with-type-2-diabetes-in/)
- [ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-developed-in/)
- [Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/)
- [Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial](https://scholariq.org/papers/efficacy-and-safety-of-oral-semaglutide-with-flexible-dose-adjustment-versus/)
- [Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled-3/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [University of Liège](https://scholariq.org/institutions/university-of-liege/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.